Literature DB >> 12697658

Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding.

Gema Díaz1, Massimo Amicosante, Dolores Jaraquemada, Richard H Butler, M Victoria Guillén, Miguel Sánchez, César Nombela, Javier Arroyo.   

Abstract

The information available on the specific function of HLA-DP and the structure-function relationships is very limited. Here, single amino acid substitutions of HLA-DPB1*02012 have been used to analyze the role of polymorphic residues of the DPbeta1 domain on DP-mediated T cell allorecognition and peptide binding. Using a panel of specific anti-HLA-DP mAb, we identified the HLA-DP residues involved in the recognition by these mAb, with a crucial role for DPbeta56 for most of the mAb assayed. Individual substitutions at residues 9, 11, 35, 55, 56 and 69 completely abrogated T cell recognition mediated by two different HLA-DPw2-allospecific T cell clones (8.3 and 8.9). Interestingly single changes at positions 9, 11, 35 and 55 of HLA-DPbeta also altered the binding of peptides AAII(12-27) and IIP(53-65), natural ligands of the HLA-DPB1*02012 molecule. Individual changes at residues located in pocket 1 (84, 85, 86 and 87 from HLA-DPbeta) led to a partial reduction in cytotoxic T lymphocyte-mediated lysis and also partially affected peptide binding. However, the simultaneous substitution of these positions completely abolished both T cell allorecognition and peptide binding, suggesting a major role for polymorphisms at pocket 1 in HLA-DP function. Molecular modeling, used to predict changes induced by amino acid substitutions, supported the functional data. Taken together, these results strongly suggest that polymorphic residues 84, 85, 86 and 87 at pocket 1, residues 9, 35 and 55 at pocket 9, and residues 11 and 69 at pockets 6 and 4 respectively play a key role in HLA-DP function, probably by modifying the way the peptide is bound within the groove of HLA-DP2 and determining changes in the conformation of the MHC-peptide complex recognized by the TCR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697658     DOI: 10.1093/intimm/dxg057

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  37 in total

1.  Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population.

Authors:  Xiuchan Guo; Yong Zhang; Ji Li; Jingchen Ma; Zuli Wei; Wenjie Tan; Stephen J O'Brien
Journal:  Hepatology       Date:  2011-01-04       Impact factor: 17.425

2.  Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.

Authors:  Massimo Andreatta; Morten Nielsen
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

3.  Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.

Authors:  Gema Díaz; Benito Cañas; Jesús Vazquez; César Nombela; Javier Arroyo
Journal:  Immunogenetics       Date:  2004-11-24       Impact factor: 2.846

4.  Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells.

Authors:  Junbao Yang; Laurel Huston; Deanna Berger; Nancy A Danke; Andrew W Liu; Mary L Disis; William W Kwok
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

5.  Extended HLA-DPB1 polymorphism: an RNA approach for HLA-DPB1 typing.

Authors:  Judith Reinders; Erik H Rozemuller; Rogier van Gent; Yvonne H A Arts-Hilkes; Jan G van den Tweel; Marcel G J Tilanus
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

6.  HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.

Authors:  Meiqun Jia; Jing Han; Dong Hang; Jie Jiang; Minjie Wang; Baojun Wei; Juncheng Dai; Kai Zhang; Lanwei Guo; Jun Qi; Hongxia Ma; Jufang Shi; Jiansong Ren; Zhibin Hu; Min Dai; Ni Li
Journal:  Tumour Biol       Date:  2015-12-28

7.  Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove.

Authors:  Lori J Silveira; Erin C McCanlies; Tasha E Fingerlin; Michael V Van Dyke; Margaret M Mroz; Matthew Strand; Andrew P Fontenot; Natalie Bowerman; Dana M Dabelea; Christine R Schuler; Ainsley Weston; Lisa A Maier
Journal:  J Immunol       Date:  2012-09-12       Impact factor: 5.422

8.  A combined DPA1~DPB1 amino acid epitope is the primary unit of selection on the HLA-DP heterodimer.

Authors:  Jill A Hollenbach; Abeer Madbouly; Loren Gragert; Cynthia Vierra-Green; Susan Flesch; Stephen Spellman; Ann Begovich; Harriet Noreen; Elizabeth Trachtenberg; Tom Williams; Neng Yu; Bronwen Shaw; Katharina Fleischhauer; Marcelo Fernandez-Vina; Martin Maiers
Journal:  Immunogenetics       Date:  2012-04-13       Impact factor: 2.846

9.  HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Catherine Metayer; Xiaomei Ma; Steve Selvin; Lisa F Barcellos; Joseph L Wiemels; John K Wiencke; Malcolm Taylor; Paul Brennan; Gary V Dahl; Priscilla Moonsamy; Henry A Erlich; Elizabeth Trachtenberg; Patricia A Buffler
Journal:  Blood       Date:  2012-08-24       Impact factor: 22.113

10.  New loci associated with chronic hepatitis B virus infection in Han Chinese.

Authors:  Zhibin Hu; Yao Liu; Xiangjun Zhai; Juncheng Dai; Guangfu Jin; Li Wang; Liguo Zhu; Yuan Yang; Jibin Liu; Minjie Chu; Juan Wen; Kaipeng Xie; Guoming Du; Qungang Wang; Yuchun Zhou; Minquan Cao; Li Liu; Yisha He; Ying Wang; Gangqiao Zhou; Weihua Jia; Jiachun Lu; Shengping Li; Jianjun Liu; Haitao Yang; Yongyong Shi; Weiping Zhou; Hongbing Shen
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.